Skip to main content
Log in

Limited prevalence of influenza A/H1N1v antibodies: footprints of the pandemic of 2010

  • Clinical and Epidemiological Study
  • Published:
Infection Aims and scope Submit manuscript

Abstract

Background

The intention of our investigation was to determine the seroprevalence of H1N1v antibodies after a pandemic by the haemagglutination inhibition (HI) test. We included the serum samples of adults who had not received vaccination against H1N1v. By means of serological footprints, the spread of infection can be investigated.

Materials and methods

Between December 2009 and May 2010, we collected 233 serum samples from healthy people aged 1–72 years and analysed the titres of H1N1v antibodies by the use of the HI test.

Results

After the pandemic, a seroprevalence of 36.9% was observed. The highest rate of seropositivity was detected in the age group of 10–19 years (60%) and the lowest rate was found in the age group of 30–39 years (22%). The seroprevalence of H1N1v antibodies in females exceeded the rate of positive men (41.5 vs. 31.8%). Almost 70% of the influenza A/H1N1v infections were passed inapparently.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Taubenberger JK, Morens DM. The pathology of influenza virus infections. Annu Rev Pathol. 2008;3:499–522.

    Article  PubMed  CAS  Google Scholar 

  2. Palese P, Shaw ML. Orthomyxoviridae: the viruses and their replication. In: Knipe DM, Howley PM, editors. Fields virology. 5th ed. Philadelphia: Lippincott Williams & Wilkins; 2007. pp. 1647–90.

    Google Scholar 

  3. Obenauer JC, Denson J, Mehta PK, et al. Large-scale sequence analysis of avian influenza isolates. Science. 2006;311:1576–80.

    Article  PubMed  CAS  Google Scholar 

  4. Wright PF, Neumann G, Kawaoka Y. Orthomyxoviruses. In: Knipe DM, Howley PM, editors. Fields virology, 5th ed. Philadelphia: Lippincott Williams & Wilkins; 2007. pp. 1691–740.

    Google Scholar 

  5. Michaelis M, Doerr HW, Cinatl J Jr. Novel swine-origin influenza A virus in humans: another pandemic knocking at the door. Med Microbiol Immunol. 2009;198(3):175–83.

    Article  PubMed  Google Scholar 

  6. Michaelis M, Doerr HW, Cinatl J Jr. An influenza A H1N1 virus revival—pandemic H1N1/09 virus. Infection. 2009;37(5):381–9.

    Article  PubMed  CAS  Google Scholar 

  7. Lagacé-Wiens PR, Rubinstein E, Gumel A. Influenza epidemiology—past, present, and future. Crit Care Med. 2010;38(4 Suppl):e1–9.

    Article  PubMed  Google Scholar 

  8. Allwinn R, Geiler J, Berger A, et al. Determination of serum antibodies against swine-origin influenza A virus H1N1/09 by immunofluorescence, haemagglutination inhibition, and by neutralization tests: how is the prevalence rate of protecting antibodies in humans? Med Microbiol Immunol. 2010;199(2):117–21.

    Article  PubMed  CAS  Google Scholar 

  9. Jones JH, Salathé M. Early assessment of anxiety and behavioral response to novel swine-origin influenza A(H1N1). PLoS One. 2009;4(12):e8032.

    Article  PubMed  Google Scholar 

  10. Buda S, Wilking H, Schweiger B, et al. Influenza-Wochenbericht. Der Arbeitsgemeinschaft Influenza. Robert Koch Institut für Kalenderwoche 8/2010. Available online at: http://www.influenza.rki.de/Wochenberichte/2009_2010/2010-08.pdf.

  11. Taubenberger JK. The origin and virulence of the 1918 “Spanish” influenza virus. Proc Am Philos Soc. 2006;150(1):86–112.

    PubMed  Google Scholar 

  12. Buda S, Wilking H, Schweiger B, et al. Influenza-Wochenbericht. Der Arbeitsgemeinschaft Influenza. Robert Koch Institut, Stand 27.04.2010.

  13. Miller E, Hoschler K, Hardelid P, et al. Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study. Lancet. 2009;375(9720):1100–8.

    Google Scholar 

  14. Hancock K, Veguilla V, Lu X, et al. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med. 2009;361(20):1945–52.

    Article  PubMed  CAS  Google Scholar 

  15. Ross T, Zimmer S, Burke D, et al. Seroprevalence following the second wave of pandemic 2009 H1N1 influenza. PLoS Curr. 2010;2:RRN1148.

    Article  PubMed  Google Scholar 

  16. Statistisches Bundesamt Deutschland. Gesundheitszustand und gesundheitsrelevantes Verhalten.

  17. Deimel H, Pfeifer K, Huber G, et al. Neue aktive Wege in Prävention und Rehabilitation. Köln: Deutscher Ärzte Verlag; 2007.

    Google Scholar 

  18. Doerr HW, Allwinn R, Cinatl J. Against the new H1N1 influenza (swine influenza): vaccinate or don’t vaccinate (all)? That is currently the question! Infection. 2009;37(5):379–80.

    Article  PubMed  CAS  Google Scholar 

  19. Statistisches Jahrbuch der Stadt Frankfurt am Main, Stand 31.12.2008.

  20. Robert Koch Institut. Epidemiologisches Bulletin, Ausgabe 50/2010 (20.12.2010).

Download references

Conflict of interest

There are no conflicts of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to H. W. Doerr.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Reinheimer, C., Allwinn, R. & Doerr, H.W. Limited prevalence of influenza A/H1N1v antibodies: footprints of the pandemic of 2010. Infection 39, 101–104 (2011). https://doi.org/10.1007/s15010-011-0105-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15010-011-0105-9

Keywords

Navigation